Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine. [PDF]
Mombo-Ngoma G +10 more
europepmc +1 more source
Plasmodium falciparum isolates: ex vivo drug response. [PDF]
Adika E +11 more
europepmc +1 more source
Computer-aided repositioning and functional <i>in vitro</i> assessment of novel PAD4 inhibitors. [PDF]
Ruiz-Hernández S +7 more
europepmc +1 more source
Trajectory of <i>Plasmodium falciparum</i> Molecular Markers of Amodiaquine Resistance in São Tomé and Príncipe. [PDF]
Té S +11 more
europepmc +1 more source
CMCL-DDI: Pharmacophore-aware cross-view contrastive learning for drug-drug interaction prediction. [PDF]
Han Y, Du L.
europepmc +1 more source
Full Prescription - Better malaria treatment for more people, MSF's experience [PDF]
MSF Brussels
core +1 more source
Strategies for mitigating emerging artemisinin-based antimalarial drug resistance in Rwanda: a promising approach for managing therapies in malaria-endemic countries. [PDF]
Muvunyi CM +14 more
europepmc +1 more source
Evaluation of in vitro drug-drug interactions of ivermectin and antimalarial compounds. [PDF]
Tipthara P +3 more
europepmc +1 more source
Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatment. [PDF]
Laird VR +22 more
europepmc +1 more source
Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023. [PDF]
Connelly SV +28 more
europepmc +1 more source

